Visceral Fat, Arterial Stiffness, and Endothelial Function in Peritoneal Dialysis Patients

Journal of Renal Nutrition

Volumn 18, Issue 6, 2008, Pages 495-502

  Lu, Qian ^a,b   Cheng, Li Tao ^b   Wang, Tao ^b   Wan, Jie ^a   Liao, Lan Lan ^a   Zeng, Jing ^b   Qin, Chao ^b   Li, Ke Ji ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53749104900     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.05.006     Document Type: Article

References (53)

1. Grodstein G.P., Blumenkrantz M.J., Kopple J.D., et al. Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19 (1981) 564-567
2. Heimburger O., Waniewski J., Werynski A., et al. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 41 (1992) 1320-1332
3. Jager K.J., Merkus M.P., Huisman R.M., et al. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 12 (2001) 1272-1279
4. Jolly S., Chatatalsingh C., Bargman J., et al. Excessive weight gain during peritoneal dialysis. Int J Artif Organs 24 (2001) 197-202
5. Behn A., and Ur E. The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol 21 (2006) 353-360
6. Ritchie S.A., and Connell J.M.C. The link between abdominal obesity, metabolism syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17 (2007) 319-326
7. Salahudeen A.K. Obesity and survival on dialysis. Am J Kidney Dis 41 (2003) 925-932
8. Snyder J.J., Foley R.N., Gilbertson D.T., et al. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64 (2003) 1838-1844
9. McDonald S.P., Collins J.F., and Johnson D.W. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient population. J Am Soc Nephrol 14 (2003) 2894-2901
10. Aslam N., Bernardini J., Fried L., et al. Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 22 (2002) 191-196
11. Bergström J., and Lindholm B. Malnutrition, cardiac disease, and mortality. Perit Dial Int 19 (1999) 309-313
12. Blacher J., Pannier B., Guerin A.P., et al. Impact of carotid stiffness on cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32 (1998) 570-574
13. Lehmann E.D. Pulse wave velocity as a marker of vascular disease. Lancet 348 (1996) 741
14. Blacher J., Guerin A.P., Pannier B., et al. Impact of carotid stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
15. Stompór T., Rajzer M., Sulowica W., et al. An association between aortic pulse wave velocity, blood pressure and chronic inflammation in ESRD patients on peritoneal dialysis. Int J Artif Organs 26 (2003) 188-195
16. Stompór T., Krzanowski M., Kusnierz-Cabala B., et al. Pulse wave velocity and proteins regulating vascular calcification and bone mineralization in patients treated with peritoneal dialysis. Nephrol Dial Transplant 21 (2006) 3605-3606
17. Lee J.W., Lee H.R., Shim J.Y., et al. Viscerally obese women with normal body weight have great brachial-ankle pulse wave velocity than non-viscerally obese women with excessive body weight. Clin Endocrinol (Oxf) 66 (2007) 572-578
18. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 15 (2004) 1983-1992
19. Arcaro G., Zamboni M., Rossi L., et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes 23 (1999) 936-942
20. Baldeweg S.E., Pink A.M., Yudkin J.S., et al. The relationship between obesity, vascular reactivity and endothelial dysfunction in subjects with non-insulin dependent diabetes mellitus. Int J Obes 24 Suppl (2000) s134-s135
21. Hashimoto M., Akishita M., Eto M., et al. The impairment of flow-mediated vasodilation in obese men with visceral fat accumulation. Int J Obes 22 (1998) 477-484
22. Van Guldener C., Janssen M., Lambert J., et al. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13 (1998) 1782-1786
23. Bergström J., Heimburger O., and Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance: which formulas should be used?. Perit Dial Int 18 (1998) 467-473
24. Asmar R., Benetos A., Topouchian J., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application study. Hypertension 26 (1995) 485-490
25. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
26. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 13 (1997) 795-803
27. Sardinha L.B., Teixeira P.J., Guedes D.P., et al. Subcutaneous central fat is associated with cardiovascular risk factors in men independently of total fatness and fitness. Metabolism 49 (2000) 1379-1385
28. Yamauchi T., Kuno T., Takada H., et al. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic hemodialysis patients. Nephrol Dial Transplant 18 (2003) 1842-1847
29. Park S.H., and Shim K.W. Reduction in visceral adiposity is highly related to improvement in vascular endothelial dysfunction among obese women: an assessment of endothelial function by radial artery pulse wave analysis. Yonsei Med J 46 (2005) 511-518
30. Steinberg H.O., Chaker H., Leamin R., et al. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
31. Steinberg H.O., Paradisi G., Hook G., et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49 (2000) 1231-1238
32. Axelsson J. Obesity in chronic kidney disease: good or bad?. Blood Purif 26 (2008) 23-29
33. Stenvinkel P., Lindholm B., Lönnqvist F., et al. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 11 (2000) 1303-1309
34. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5 (2002) 377-383
35. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
36. Yamachi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
37. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κ B signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
38. Axelsson J., Qureshi A.R., Suliman M.E., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
39. Ma S.W., Tomlinson B., and Benzie I.F. A study of the effect of oral glucose loading on plasma oxidant: antioxidant balance in normal subjects. Eur J Nutr 44 (2005) 250-254
40. Jang Y., Kim O.Y., Ryu H.J., et al. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J Lipid Res 44 (2003) 2356-2364
41. Williams M.J.A., Sutherland W.H.F., McCormick M.P., et al. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol 33 (1999) 1050-1055
42. Clarkson P., Celermajer D.S., Donald A.E., et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low-density lipoprotein cholesterol levels. J Am Coll Cardiol 28 (1996) 573-579
43. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998) 1695-1701
44. Wieslander A., Forsback G., Svensson E., et al. Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluids. Adv Perit Dial 12 (1996) 57-60
45. Welten A.G., Schalkwijk C.G., ter Wee P.M., et al. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 23 (2003) 213-221
46. Odani H., Shinzato T., Usami J., et al. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. FEBS Lett 427 (1998) 381-385
47. Schwedler S., Schinzel R., Vaith P., et al. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?. Kidney Int 78 Suppl (2001) S32-S36
48. Barbosa-Silva M.C.G., and Barros A.J.D. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 8 (2005) 311-317
49. Stall S.H., Ginsberg N.S., DeVita M.V., et al. Comparison of five body-composition methods in peritoneal dialysis patients. Am J Clin Nutr 64 (1996) 125-130
50. Kushner R.F., de Vries P.M., and Gudivake R. Use of bioelectrical impedance analysis measurements in the clinical management of patients undergoing dialysis. Am J Clin Nutr 64 Suppl (1996) s503-s509
51. Medici G., Mussi C., Fantuzzi A.L., et al. Accuracy of eight-polar bioelectrical impedance analysis for the assessment of total and appendicular body composition in peritoneal dialysis patients. Eur J Clin Nutr 59 (2005) 932-937
52. Demura S., and Sato S. Prediction of visceral fat area at the umbilicus level using fat mass of the trunk: the validity of bioelectrical impedance analysis. J Sports Sci 25 (2007) 823-833
53. Locatelli F., Fouque D., Heimburger O., et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 17 (2002) 563-572